Suven Pharmaceuticals Ltd. (BSE: 530239, NSE: SUVENPHARM), a technology-focused Contract Development and Manufacturing Organization (CDMO) headquartered in Hyderabad, announced a 12% year-over-year revenue growth for the second quarter of fiscal year 2025. Driven by a strengthened pipeline, increased customer requests, and key expansions, the company reported revenues of INR 258 crore, marking a steady path […]
Suven Pharmaceuticals (Suven Pharma), CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad and CSIR-National Institute of Interdisciplinary Science & Technology, Thiruvananthapuram have forged an agreement for the transfer of the process technology and manufacturing of the Covid drugs – Molnupiravir and 2-DG. According to Suven Pharmaceuticals, it is a related party transaction with one of its […]
